Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is aimed to evaluate response rate of the antihypertensive treatment with a calcium antagonist in real life practice, to evaluate patients' quality of life and to collect the following Serbia-specific epidemiology data on hypertension: demographic data, patents characteristics, and patients' management/treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Subject population with essential arterial hypertension currently receiving treatment with a calcium antagonist |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate proportion of patients on antihypertensive pharmacological treatment reaching SBP goals according to the ESC 2007 guidelines (<140 mmHg*). | 24 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate proportion of patients on antihypertensive pharmacological treatment reaching DBP goals according to the ESC 2007 guidelines (<90 mmHg*). | 24 weeks | |
| To collect local epidemiological date on patients with hypertension (demographic data; hypertension management data: treatment, treatment changes and tolerability data). |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Speciality care clinics
Not provided
| Name | Affiliation | Role |
|---|---|---|
| prof. dr Zorana Vasiljevic | Clinical Center of Serbia, Belgrade | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Belgrade | Serbia | ||||
| Research Site |
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 24 weeks |
| To evaluate patients quality of life after 12 and 24 weeks by using patients quality of life questionnaire | 24 weeks |
| Čačak |
| Serbia |
| Research Site | Kamenitz | Serbia |
| Research Site | Kragujevac | Serbia |
| Research Site | Niš | Serbia |
| Research Site | Niška Banja | Serbia |
| Research Site | Pančevo | Serbia |
| Research Site | Šabac | Serbia |